1st Quarter - Report — FABIANI & COMPANY for AFRAXIS (2010)

Firm

FABIANI & COMPANY

Client

AFRAXIS

Income

$30,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Securing federal R&D for treatment of central nervous system diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
JEFFREY STUART WIENER	—

Contacted: Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Natl Institute of Mental Health (NIMH); SENATE

Defense DEF

Securing federal R&D for treatment of central nervous system diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
JEFFREY STUART WIENER	—

Contacted: Natl Institute of Mental Health (NIMH); Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Medical/Disease Research/Clinical Labs MED

Securing federal R&D for treatment of central nervous system diseases

Lobbyist	Covered position, as disclosed
ELIZABETH BARROWS	—
JEFFREY STUART WIENER	—

Contacted: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Natl Institute of Mental Health (NIMH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.